SAIKI Shinji
- Articles
- Shared Metabolic Profile of Caffeine in Parkinsonian Disorders.
Takeshige-Amano Haruka; Saiki Shinji; Fujimaki Motoki; ...
Movement disorders : official journal of the Movement Disorder Society/35(8)/pp.1438-1447, 2020-08 - Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease.
Yamaguchi Akihiro; Ishikawa Kei-Ichi; Inoshita Tsuyosh...
Stem cell reports/14(6)/pp.1060-1075, 2020-06-09 - Nonmercaptalbumin as an oxidative stress marker in Parkinson's and PARK2 disease.
Ueno Shin-Ichi; Hatano Taku; Okuzumi Ayami; Saiki Shi...
Annals of clinical and translational neurology/7(3)/pp.307-317, 2020-03 - Metabolomic analysis revealed mitochondrial dysfunction and aberrant choline metabolism in MPP+-exposed SH-SY5Y cells.
Amo Taku; Oji Yutaka; Saiki Shinji; Hattori Nobutaka
Biochemical and biophysical research communications/519(3)/pp.540-546, 2019-11-12 - Neuroprotective effects of memantine via enhancement of autophagy.
Hirano Kazuoki; Fujimaki Motoki; Sasazawa Yukiko; Yama...
Biochemical and biophysical research communications/518(1)/pp.161-170, 2019-10-08 - A metabolic profile of polyamines in parkinson disease: A promising biomarker.
Saiki Shinji; Sasazawa Yukiko; Fujimaki Motoki; Kamaga...
Annals of neurology/86(2)/pp.251-263, 2019-08 - Iron Supply via NCOA4-Mediated Ferritin Degradation Maintains Mitochondrial Functions.
Fujimaki Motoki; Furuya Norihiko; Saiki Shinji; Amo T...
Molecular and cellular biology/39(14), 2019-07-15 - Multi-year whole-blood transcriptome data for the study of onset and progression of Parkinson's Disease.
Valentine Matthew N. Z.; Hashimoto Kosuke; Fukuhara Take...
Scientific data/6(1)/pp.20-20, 2019-04-05 - Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy.
Mori Akio; Ishikawa Kei-Ichi; Saiki Shinji; Hatano Ta...
PloS one/14(9)/p.e0223113, 2019 - Basic Neuroscience 生化学(分子生物学)神経変性疾患の血清・血漿診断マーカー
斉木 臣二
Annual Review神経/2019/pp.33-40, 2019-03 - Metabolomics-based identification of metabolic alterations in PARK2.
Okuzumi Ayami; Hatano Taku; Ueno Shin-Ichi; Ogawa Takash...
Annals of clinical and translational neurology/6(3)/pp.525-536, 2019-03 - p150glued deficiency impairs effective fusion between autophagosomes and lysosomes due to their redistribution to the cell periphery.
Ishikawa Kei-Ichi; Saiki Shinji; Furuya Norihiko; Imam...
Neuroscience letters/690/pp.181-187, 2019-01-18 - Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson's Disease.
Ueno S. I.; Saiki S.; Fujimaki M.; Takeshige-Amano H.; Ha...
Cells/8(1), 2018-12-29 - NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy.
Furuya Norihiko; Kakuta Soichiro; Sumiyoshi Katsuhiko; ...
EMBO reports/19(12), 2018-12 - パーキンソン病のバイオマーカー
斉木 臣二
Medical Science Digest/44(13)/pp.705-706, 2018-11 - 【Parkinson病の診断と治療update】 Parkinson病のバイオマーカー
波田野 琢; 斉木 臣二; 服部 信孝
神経内科/89(3)/pp.227-233, 2018-09 - Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease.
Ren Qian; Ma Min; Yang Jun; Nonaka Risa; Yamaguchi A...
Proceedings of the National Academy of Sciences of the United States of America/115(25)/pp.E5815-E5823-E5823, 2018-06-19 - 【パーキンソン病(第2版)-基礎・臨床研究のアップデート-】検査・診断 診断バイオマーカー
斉木 臣二
日本臨床/76(増刊4 パーキンソン病)/pp.326-329, 2018-05 - パーキンソン病治療薬の開発展望
笹澤 有紀子; 斉木 臣二; 井本 正哉
バイオインダストリー/35/pp.1-9, 2018 - Immunocytochemical Monitoring of PINK1/Parkin-Mediated Mitophagy in Cultured Cells.
Fujimaki Motoki; Saiki Shinji; Sasazawa Yukiko; Ishika...
Methods in molecular biology (Clifton, N.J.)/1759/pp.19-27, 2018 - Connectome analysis with diffusion MRI in idiopathic Parkinson's disease: Evaluation using multi-shell, multi-tissue, constrained spherical deconvolution.
Kamagata Koji; Zalesky Andrew; Hatano Taku; Di Biase Mar...
NeuroImage. Clinical/17/pp.518-529, 2018 - Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice.
Sato Shigeto; Uchihara Toshiki; Fukuda Takahiro; Noda ...
Scientific reports/8(1)/pp.2813-2813, 2018-02-12 - Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease.
Fujimaki Motoki; Saiki Shinji; Li Yuanzhe; Kaga Naoko...
Neurology/90(5)/pp.e404-e411-e411, 2018-01-30 - 【Theオートファジー 研究者たちの集大成が見える最新ビジュアルテキスト】(第5章)オートファジーの病態生理的意義 オートファジーと神経変性・パーキンソン病
斉木 臣二
実験医学/35(15)/pp.2628-2633, 2017-09 - Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease.
Saiki S.; Hatano T.; Fujimaki M.; Ishikawa K. I.; Mori A...
Scientific reports/7(1)/pp.7328-7328, 2017-08-04 - more...
- Shared Metabolic Profile of Caffeine in Parkinsonian Disorders.